< Back to catalogue
Sitagliptin + Metformin
August 3, 2026Sugammadex
August 3, 2026PHARMAZAC
Sitagliptin
Sitagliptin | DPP‑4 inhibitor | Business Development
| F.C. TABS 25 MG/TAB |
| F.C. TABS 50 MG/TAB |
| F.C. TABS 100 MG/TAB |
| F.C. TABS 25 MG/TAB |
| F.C. TABS 50 MG/TAB |
| F.C. TABS 100 MG/TAB |
| ACTIVE SUBSTANCE | |
|---|---|
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| STATUS | Available |
| THERAPEUTIC AREA |
